logo SSARV/AScS Swiss Sarcoidosis Association
SSARV - AScS

Chairs: Bob Baughman & Dominique Valeyre

The objective of the task force is to produce an updated evidence-based clinical guideline on sarcoidosis focused on treatment, as no guideline was made available since 1999. A very important point will be (a) strict methodology in formulating questions and sub-questions, reporting evidence-based data drawn around sub-questions from the literature and apply a GRADING approach, (b) tight interactions within the TF group using an interactive method and (c) tight implication of patient representatives.

https://taskforces.ersnet.org/item/sarcoidosis-treatment

Mindfulness Meditation against depression
http://www.bbc.com/news/health-32380183

Source: Lancet:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62222-4/fulltext

Comments by Dr Linda Charvoz Psychologist - Psychotherapist, Lausanne, our psychologist

for the  Stress Management Program of the Swiss Sarcoidosis Association (SSARV-AScS)

We must stress that depression must absolutely be treated by a doctor.
If a person has had one depression crisis, he or she has 50 to 60% risk of relapse.
If a person has experienced 2 periods of depression, the risk of a third crisis reaches 70% and so on...
The rate of risk increases with the number of depression crises already suffered.
Speaking about depression, Mindfulness Based Cognitive Therapy (MBCT)  is mostly used to decrease the relapse rate.
This method is mostly recommended for people who already have recovered from depression.
However, all the methods used to prevent relapse (medical treatment and control) are strictly to be continued.